These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23021595)

  • 21. The use of methotrexate in rheumatoid arthritis.
    Borchers AT; Keen CL; Cheema GS; Gershwin ME
    Semin Arthritis Rheum; 2004 Aug; 34(1):465-83. PubMed ID: 15305245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis.
    Previtali V; Petrovic K; Peiró Cadahía J; Troelsen NS; Clausen MH
    Bioorg Med Chem; 2020 Jan; 28(2):115247. PubMed ID: 31843461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative use of methotrexate.
    Heldmann F; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S110-3. PubMed ID: 21044442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
    Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH
    Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis.
    Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T
    Clin Immunol; 1999 Apr; 91(1):84-9. PubMed ID: 10219258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study.
    di Munno O; Mazzantini M; Sinigaglia L; Bianchi G; Minisola G; Muratore M; la Corte R; di Matteo L; Canesi B; Caminiti M; Broggini M; Adami S
    J Rheumatol; 2004 Jul; 31(7):1305-9. PubMed ID: 15229948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects and management of side effects of methotrexate in rheumatoid arthritis.
    Albrecht K; Müller-Ladner U
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S95-101. PubMed ID: 21044440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
    Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
    Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
    Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
    Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Nagano A
    Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis.
    Nakajima A; Hakoda M; Yamanaka H; Kamatani N; Kashiwazaki S
    Ann Rheum Dis; 1996 Apr; 55(4):237-42. PubMed ID: 8733440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies.
    Ikeda K; Watanabe K; Hirai T; Tanji K; Miyashita T; Nakajima S; Uomori K; Morimoto S; Takamori K; Ogawa H; Takasaki Y; Sekigawa I
    Intern Med; 2017; 56(10):1147-1152. PubMed ID: 28502927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?
    Aletaha D; Smolen JS
    Rheum Dis Clin North Am; 2019 Aug; 45(3):315-324. PubMed ID: 31277746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.